Protagonist Therapeutics, Inc. (PTGX)

91.30 -2.94 (-3.12%) USD  |  NASDAQ  |  Mar 03, 16:00
90.80 -0.50 (-0.55%) After-Hours: 06:35
More

Protagonist Therapeutics Quarterly Revenue Estimates

Quarterly Revenue Estimates Chart

View Quarterly Revenue Estimates for PTGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Revenue Estimates Range, Past 5 Years

View Quarterly Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Revenue Estimates Benchmarks

View Quarterly Revenue Estimates Benchmarks
Start Trial
Johnson & Johnson Upgrade
ADMA Biologics, Inc. Upgrade
Glaukos Corp. Upgrade
Krystal Biotech, Inc. Upgrade
Olema Pharmaceuticals, Inc. Upgrade